Skip to content

The Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Nausea and Vomiting in Patients Undergoing Orthognathic Surgery: A Randomized Controlled Trial

The Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Nausea and Vomiting in Patients Undergoing Orthognathic Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001288
Enrollment
Unknown
Registered
2025-06-27
Start date
2025-12-30
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental and maxillofacial deformities

Interventions

Intervention group:Transcutaneous electrical acupoint stimulation treatment: Neiguan (PC6) acupoint, starting at level 1, with gradual increase in stimulation intensity until the patient feels a tingl
Control Group:Wear a powered and displayed non-stimulation wristband, which is also activated immediately once the patient regains consciousness from general anesthesia at the end of the surgery, and

Sponsors

West China Hospital of Stomatology,Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1) Female patients; 2) Aged 18 to 50 years; 3) Body Mass Index (BMI) ranging from 18.5 to 27.9 kg/m²; 4) Undergoing bimaxillary orthognathic surgery; 5) General anesthesia; 6) American Society of Anesthesiologists (ASA) physical status I to III; 7) After being informed of the study's purpose and content, the patient or their family members signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Metal contact allergy; 2) Presence of metallic implants such as a pacemaker, cochlear implant, or other metal-containing devices; 3) Skin damage or scars at the wrist area; 4) History of cranial or mental disorders; 5) History of gastrointestinal surgery or chronic gastrointestinal diseases; 6) Abnormal liver or kidney function; 7) Patients with nausea and vomiting or who have used antiemetic drugs one day before surgery.

Design outcomes

Primary

MeasureTime frame
Incidence of PONV within 24 hours;

Secondary

MeasureTime frame
Pain assessment;Number of days in hospital;Electrical stimulation-related complications;The time of first oral intake after surgery;Postoperative patient satisfaction score;The highest PON score at each postoperative time interval ;Incidence of PON, incidence and frequency of POV at each time interval;Incidence of PON, incidence of POV, and rescue antiemetic rate within 24 hours;

Countries

China

Contacts

Public ContactBi Xiaoqin

West China Hospital of Stomatology,Sichuan University

hxbxq@163.com+86 135 4116 8806

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026